AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $210.40
-
Support level$197.65
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)79.8
- ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $164.99 | $216.66 | 89.2% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $188.84 | $194.99 | $204.17 | $208.43 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.5%
-
In the next month12.5%
-
In the next year54.4%
| Period | Value |
|---|---|
| Historical (5 year) | 22.8% |
| Last month | 22.2% |
| Current estimate | 20.2% |
| Next month forecast | 22.1% |